Takeda releases internal probe over bad ad

Share this article:

Japanese drugmaker Takeda has released the results of an internal probe over an inappropriate ad for blood pressure medicine BIopress, which, according to the Wall Street Journal, utilized an incorrect chart and “raised suggestions of manipulated trial data.” The company denies wrongdoing. The report is only available in Japanese, however, and WSJ reports that questions regarding an English version have gone unanswered, raising questions on whether the company is trying to be transparent, or merely to appear transparent.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.